Skip to Content

User Reviews for Ifosfamide

Also known as: Ifex

Ifosfamide has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of those users who reviewed Ifosfamide reported a positive effect, while 100% reported a negative effect.

Condition Avg. Rating Reviews Compare
Cancer  
1.0
1 reviews 24 medications
Summary of Ifosfamide reviews 1.0 1 reviews

Reviews may be moderated or edited before publication to correct grammar and spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest in the medication will not be published. As reviews and ratings are subjective and self-reported, this information should not be used as the basis for any statistical analysis or scientific studies.

mickey ยท Taken for less than 1 month March 4, 2021

For Cancer: “Overall, my experience with ifosfamide was disasterous. Used to treat my soft tissue sarcoma cancer, the drug did shrink the tumor, but the main side effect was total devastation of my kidneys. If you don't have working kidneys, you are on the fast track to #1 Dialysis and #2 Death. From what I can tell, ifosfamide is a vicious nephrotoxic drug not safe for animals or people. A study from Canada involving 163,000 chemotherapy subjects, varied drug regimens, showed that 10 % of them wound up hospitalized with serious kidney damage, often irreversible. And for those with advanced tumors, and that includes myself, our chances jumped up to 41 percent. These are odds not even high risk gamblers would accept. I am trying to find out the dose of infosfamide I was given, and if there was any effort made to prevent the horrific side effects of this drug. I feel like I was attack from behind by an unknown assailant. As a result, my prognosis is grim.”

1 / 10
Was this helpful?YesNo

This information is NOT intended to endorse any particular medication. While these reviews might be helpful, they are not a substitute for the expertise, knowledge and judgement of healthcare practitioners.